Show simple item record

dc.contributor.authorRamamoorthi, Kartik
dc.contributor.authorLin, Yingxi
dc.date.accessioned2016-04-08T16:44:56Z
dc.date.available2016-04-08T16:44:56Z
dc.date.issued2011-04
dc.identifier.issn14714914
dc.identifier.urihttp://hdl.handle.net/1721.1/102223
dc.description.abstractGABA (γ-aminobutyric acid) is the major inhibitory neurotransmitter in the brain. The GABAergic system is indispensable for maintaining the balance between excitation and inhibition (E/I balance) required for normal neural circuit function. E/I imbalances that result from perturbations in the development of this system, ranging from the generation of inhibitory neurons to the formation of their synaptic connections, have been implicated in several neurodevelopmental disorders. In this review, we discuss how impairments at different stages in GABAergic development can lead to disease states. We also highlight recent studies which show that modulation of the GABAergic system can successfully reverse cognitive deficits in disease models and suggest that therapeutic strategies targeting the GABAergic system could be effective in treating neurodevelopmental disorders.en_US
dc.description.sponsorshipMcGovern Institute for Brain Research at MITen_US
dc.description.sponsorshipMIT Presidential Marcus Fellowship to Honor Norman B. Leventhalen_US
dc.description.sponsorshipWhitehall Foundation (Research Grant)en_US
dc.description.sponsorshipJohn Merck Funden_US
dc.description.sponsorshipMassachusetts Institute of Technology. James H. Ferry Funden_US
dc.description.sponsorshipSimons Foundation. Autism Research Initiativeen_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Grant MH091220-01)en_US
dc.language.isoen_US
dc.publisherElsevieren_US
dc.relation.isversionofhttp://dx.doi.org/10.1016/j.molmed.2011.03.003en_US
dc.rightsCreative Commons Attribution-Noncommercial-NoDerivativesen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/en_US
dc.sourcePMCen_US
dc.titleThe contribution of GABAergic dysfunction to neurodevelopmental disordersen_US
dc.typeArticleen_US
dc.identifier.citationRamamoorthi, Kartik, and Yingxi Lin. “The Contribution of GABAergic Dysfunction to Neurodevelopmental Disorders.” Trends in Molecular Medicine 17, no. 8 (August 2011): 452–462.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Brain and Cognitive Sciencesen_US
dc.contributor.departmentMcGovern Institute for Brain Research at MITen_US
dc.contributor.mitauthorRamamoorthi, Kartiken_US
dc.contributor.mitauthorLin, Yingxien_US
dc.relation.journalTrends in Molecular Medicineen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsRamamoorthi, Kartik; Lin, Yingxien_US
dc.identifier.orcidhttps://orcid.org/0000-0002-7002-1275
mit.licensePUBLISHER_CCen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record